Latest Press Releases

Aster Guardians Global Nursing Award 2025 Worth US$250,000 Now Open for Nominations Worldwide

Registered nurses from across the world can submit their applications through www.asterguardians.com in their preferred languages by February 10, 2025 . DUBAI, United Arab Emirates, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Aster DM Healthcare ...

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

TAIPEI, Taiwan, Dec. 23, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADC) and active immunotherapies (4174. ...

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

PR Newswire BENGALURU, India, Dec. 24, 2024 Manipal Hospital Old Airport Road Raises Cancer Awareness with 'Breaking Barriers, Building Awareness' BENGALURU, India, Dec. 24, 2024 /PRNewswire/ -- For many youngsters, cancer remains an ...

Truckloads of Cheer: Truck Master Warranty Donates Toy Trucks to Children's Hospitals for the Holidays

PR Newswire AKRON, Ohio and KANSAS CITY, Kan., Dec. 23, 2024 AKRON, Ohio and KANSAS CITY, Kan., Dec. 23, 2024 /PRNewswire/ -- Truck Master Warranty, a leader in commercial medium and heavy-duty truck protection plans, donated hundreds of toy ...

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the toxic illegal drug and overdose crisis

Canada NewsWire OTTAWA, ON, Dec. 23, 2024 OTTAWA, ON, Dec. 23, 2024 /CNW/ - Canada is facing a tragic public health crisis that has left no community untouched. The overdose crisis is driven by a dangerous, illegal toxic drug supply. The ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

PR Newswire SILVER SPRING, Md., Dec. 23, 2024 SILVER SPRING, Md., Dec. 23, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a ...

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

PR Newswire VANCOUVER, BC, Dec. 23, 2024 Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 23, 2024 /PRNewswire/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the ...

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

PR Newswire CHENGDU, China, Dec. 23, 2024 CHENGDU, China, Dec. 23, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the ...

Nearly 50% of Young People Resolve to Quit Nicotine in 2025

PR Newswire WASHINGTON, Dec. 23, 2024 EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024 /PRNewswire/ -- Almost half (48%) of young people aged 18-24 are making quitting nicotine a priority for their ...

Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

PR Newswire MARLBOROUGH, Mass., Dec. 23, 2024 – GEMTESA® is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH – MARLBOROUGH, Mass., Dec. 23, 2024 ...

Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment

PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Baird Medical (NASDAQ: BDMD), a leader in minimally invasive Microwave Ablation (MWA) technology, recently sponsored another advanced MWA training session in New ...

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

PR Newswire SAN DIEGO and CALGARY, AB, Dec. 23, 2024 Promising BRACELET-1 results in HR+/HER2- metastatic breast cancer lay the foundation for potential registration-enabling study and accelerated approval Advancing gastrointestinal ...

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

PR Newswire NEWTOWN, Pa., Dec. 23, 2024 Investigational agent in development for treatment or prevention of H5N1 Bird Flu Phase 1 dosing completed in healthy volunteers Potent inhibition of drug-resistant and bird flu viruses in ...

Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

PR Newswire HONG KONG, Dec. 23, 2024 HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University ...

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

PR Newswire SHANGHAI, Dec. 22, 2024 SHANGHAI, Dec. 22, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, ...

Steps to Take After a Bicycle Accident: Protecting Your Rights

PR Newswire FORT LAUDERDALE, Fla., Dec. 22, 2024 FORT LAUDERDALE, Fla., Dec. 22, 2024 /PRNewswire/ -- Bicycle accidents can leave victims with severe injuries and uncertainty about what steps to take next. The Law Offices of Jason Turchin ...

Second Opinion Expert Announces Filing of U.S. Patent for Method of Generating Medical Opinions Using Artificial Intelligence

PR Newswire DANA POINT, Calif., Dec. 22, 2024 Patent leverages AI technology to improve patient outcomes and reduce cost of care DANA POINT, Calif., Dec. 22, 2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading ...

Registration Is Now Open for Women's Health and Menopause, a Continuing Medical Education Course Offered by Harvard Medical School and Mass General Brigham

PR Newswire BOSTON, Dec. 21, 2024 Course Director: Deborah Gomez Kwolek, MD, FACP, FAMWA, MSCP and Course Co-Director: Mahmooda Qureshi, MD, MSCP Join keynote speakers Jan L. Shifren, MD, MSCP, Anna Cabeca, DO, FACOG, ABAARM, Heather Hirsch, ...

Vintage Philanthropy: Hollander Foundation Pours $25,000 into Prostate Cancer Research from Wine-Making Proceeds

PR Newswire GAINESVILLE, Fla., Dec. 21, 2024 The Hollander Foundation, dedicated to supporting prostate cancer research, awarded its annual gift to Franklin Huang, M.D. of the UCSF School of Medicine. Dr. Huang's lab examines the genetics of ...

YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR

PR Newswire SHANGHAI, Dec. 21, 2024 SHANGHAI, Dec. 21, 2024 /PRNewswire/ -- YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing ...

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors

PR Newswire PLAINSBORO, N.J., Dec. 20, 2024 PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) approved Alhemo® (concizumab-mtci) injection as a once-daily ...

FDA Approves First Medication for Obstructive Sleep Apnea

PR Newswire SILVER SPRING, Md., Dec. 20, 2024 SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

PR Newswire INDIANAPOLIS, Dec. 20, 2024 Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms ...

Study Finds Telemedicine Improves Care for Children with Eye Cancer

PR Newswire NEW YORK, Dec. 20, 2024 The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how telemedicine improves outcomes for children with retinoblastoma through e-learning and virtual ...

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

PR Newswire VANCOUVER, BC, Dec. 20, 2024 USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its ...

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

PR Newswire INCHEON, South Korea, Dec. 18, 2024 - Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights ...

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

PR Newswire CARLSBAD, Calif., Dec. 19, 2024 CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an ...

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PR Newswire LOS ANGELES, Dec. 18, 2024 LOS ANGELES, Dec. 18, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic ...

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

PR Newswire BERKELEY HEIGHTS, N.J., Dec. 18, 2024 BERKELEY HEIGHTS, N.J., Dec. 18, 2024 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals ...

Syrian American Medical Society (SAMS) Reaffirms Commitment to Syria's Health Crisis Amid Continued Power Transition

PR Newswire WASHINGTON, Dec. 18, 2024 Volunteer Doctors Introduce Health Assessment Report, Outlining Urgent Medical Solutions for Syria WASHINGTON, Dec. 18, 2024 /PRNewswire/ -- The Syrian American Medical Society (SAMS), global leader ...

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

PR Newswire SCOTTSDALE, Ariz., Dec. 18, 2024 Findings from retrospective chart review of patients with suspected Parkinson's disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves ...

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

PR Newswire DETROIT, Dec. 18, 2024 Karmanos is the first in the world with access to this innovative treatment that uses radiofrequencies to target and shrink cancerous tumors DETROIT, Dec. 18, 2024 /PRNewswire/ -- The Barbara Ann ...

Latest Press Releases

Premium Press Releases »

Aster Guardians Global Nursing Award 2025 Worth US$250,000 Now Open for Nominations Worldwide

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

Press Releases »

Empowering Youth: Students Learn About Cancer Detection, Treatment, and Hope

Truckloads of Cheer: Truck Master Warranty Donates Toy Trucks to Children's Hospitals for the Holidays

Statement from the Minister of Mental Health and Addictions and Associate Minister of Health on the toxic illegal drug and overdose crisis

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Keymed Biosciences Announces Approval Of Stapokibart For The Treatment Of Chronic Rhinosinusitis With Nasal Polyposis

Nearly 50% of Young People Resolve to Quit Nicotine in 2025

Sumitomo Pharma America Announces U.S. FDA Approval of GEMTESA® (vibegron) for Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia

Baird-Sponsored Microwave Ablation Training Enhances Thyroid Treatment

Oncolytics Biotech® Highlights 2024 Achievements and Prepares for an Influential 2025 with Promising Breast and GI Cancer Data

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

Steps to Take After a Bicycle Accident: Protecting Your Rights

Second Opinion Expert Announces Filing of U.S. Patent for Method of Generating Medical Opinions Using Artificial Intelligence

Registration Is Now Open for Women's Health and Menopause, a Continuing Medical Education Course Offered by Harvard Medical School and Mass General Brigham

Vintage Philanthropy: Hollander Foundation Pours $25,000 into Prostate Cancer Research from Wine-Making Proceeds

YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors

FDA Approves First Medication for Obstructive Sleep Apnea

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

Study Finds Telemedicine Improves Care for Children with Eye Cancer

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

Syrian American Medical Society (SAMS) Reaffirms Commitment to Syria's Health Crisis Amid Continued Power Transition

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

Medindia Newsletters